+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States and Canada Cervical Cancer Screening Market, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Company Analysis

  • PDF Icon

    Report

  • 90 Pages
  • November 2021
  • Region: Canada, United States
  • Renub Research
  • ID: 5504323
In the North America, cervical cancer screening is a public health success; it is the fourth most frequent cancer prevailing in women over 30 years. It affects the lower part of the uterus (womb). Cervical cancer is a malignancy of cervical cells and is mostly caused by the Human papillomavirus (HPV) virus. In 2020, as per the American Cancer Society, around 13,800 new cases of invasive cervical cancer were being diagnosed, and about 4,290 women died from cervical cancer in the United States.

Notwithstanding, increasing awareness among the general population regarding the prevention, care, and treatment of cervical cancer, rise in certain behaviors, such as smoking, certain genetic factors, and weak immune system are all linked to the growth of the United States and Canada cervical cancer screening market. The rising number of cervical cancer cases has fueled the demand for screening programs. According to this report, United States and Canada Cervical Cancer Screening Market will reach US$ 8.2 Billion by 2027.

COVID-19 Impacts on the United States and Canada Cervical Cancer Screening Industry


The sudden outbreak of the COVID-19 pandemic had led to the implementation of stringent lockdown regulations across the United States and Canada, resulting in disruptions of Cervical Cancer Screening. Cervical cancer screening declined to meagre numbers in US and Canada due to the coronavirus pandemic. Most non-urgent cervical cancer appointments have been cancelled in the wake of COVID-19.

United States and Canada Cervical Cancer Screening Market Size was US$ 8 Billion in 2021


Besides, the growing number of cervical cancer cases surge the demand for HPV testing and PAP tests in the United States and Canada. Pap test is approved for all women between the ages of 21 to 65 every three years, and women between 30-65 are recommended to have both Pap and HPV tests. Pap test or smear test is a method that doctors use to find cell changes or abnormal cells in the cervix. Pap tests are the most preferred tests in the United States and Canada to detect cervical cancer.

Furthermore, Human papillomavirus (HPV) is the most common sexually transmitted disease (STD) in the United States. HPV tests are DNA-based and allow the detection of specific strains of the virus in the specimen. HPV tests during primary screening help in the detection of abnormal cells that become cancerous. This helps in early disease prevention, providing healthcare professionals to opt for various treatment and preventive options. United States and Canada Cervical Cancer Screening Industry is expected to grow with a CAGR of 0.41% from 2021 to 2027.

This report “United States and Canada Cervical Cancer Screening Market by United States – Cervical Cancer Test Analysis (Population – Cervical Cancer Test (Screening), Pap smear Test Population, HPV DNA Test Population) by United States – Cervical Cancer Test Market (Pap Smear Test Market,HPV DNA Test Market) Canada – Cervical Cancer Test Analysis (Population – Cervical Cancer Test (Screening), Pap Smear Test Population, HPV DNA Test Population) Market – Cervical Cancer Test (Screening) (Pap Smear Test Market, HPV DNA Test Market)” provides a detailed analysis of United States and Canada Cervical Cancer Screening Industry.

United States – Cervical Cancer Test Analysis has been covered from 3 viewpoints


1. Population – Cervical Cancer Test (Screening)
2. Pap smear Test Population
3. HPV DNA Test Population

United States Cervical Cancer Mortality


Market – Cervical Cancer Test (Screening) has been covered from 2 viewpoints


1. Pap Smear Test Market
2. HPV DNA Test Market

Canada – Cervical Cancer Test Analysis has been covered from 3 viewpoints


1. Population – Cervical Cancer Test (Screening)
2. Pap Smear Test Population
3. HPV DNA Test Population

Canada Cervical Cancer Mortality


Market – Cervical Cancer Test (Screening) has been covered from 2 viewpoints


1. Pap Smear Test Market
2. HPV DNA Test Market

Table of Contents

1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. North America Cervical Cancer Test (Screening) Analysis
5.1 North America Cervical Cancer Test Population
5.1.1 Pap Smear Test Population
5.1.2 HPV DNA Test Population
5.2 North America Cervical Cancer Test (Screening) Market
5.2.1 Pap Smear Test Market
5.2.2 HPV DNA Test Market
6. Market Share – By Countries
6.1 Market Share – By Countries
6.1.1 Pap Smear Test Market
6.1.2 HPV DNA Test Market
7. United States – Cervical Cancer Test Analysis
7.1 Population – Cervical Cancer Test (Screening)
7.1.1 Pap smear Test Population
7.1.2 HPV DNA Test Population
7.2 United States Cervical Cancer Mortality
7.3 Market – Cervical Cancer Test (Screening)
7.3.1 Pap Smear Test Market
7.3.2 HPV DNA Test Market
8. Canada – Cervical Cancer Test Analysis
8.1 Population – Cervical Cancer Test (Screening)
8.1.1 Pap Smear Test Population
8.1.2 HPV DNA Test Population
8.2 Canada Cervical Cancer Mortality
8.3 Market – Cervical Cancer Test (Screening)
8.3.1 Pap Smear Test Market
8.3.2 HPV DNA Test Market
List Of Figures:
Figure-01: North America Cervical Cancer Test Population (Thousand), 2016 – 2021
Figure-02: Forecast for – North America Cervical Cancer Test Population (Thousand), 2022 – 2027
Figure-03: North America – Pap Smear Test Population (Thousand), 2016 – 2021
Figure-04: North America – Forecast for Pap Smear Test Population (Thousand), 2022 – 2027
Figure-05: North America – HPV DNA Test Population (Thousand), 2016 – 2021
Figure-06: North America – Forecast for HPV DNA Test Population (Thousand), 2022 – 2027
Figure-07: North America – Cervical Cancer Test (Screening) Market (Million US$), 2016 – 2021
Figure-08: North America – Forecast for Cervical Cancer Test (Screening) Market (Million US$), 2022 – 2027
Figure-09: North America – Pap Smear Test Market (Million US$), 2016 – 2021
Figure-10: North America – Forecast for Pap Smear Test Market (Million US$), 2022 – 2027
Figure-11: North America – HPV DNA Test Market (Million US$), 2016 – 2021
Figure-12: North America – Forecast for HPV DNA Test Market (Million US$), 2022 – 2027
Figure-13: United States – Cervical Cancer Test Population (Thousand), 2016 – 2021
Figure-14: United States – Forecast for Cervical Cancer Test Population (Thousand), 2022 – 2027
Figure-15: United States – Pap smear Test Population (Thousand), 2016 – 2021
Figure-16: United States – Forecast for Pap smear Test Population (Thousand), 2022 – 2027
Figure-17: United States – HPV DNA Test Population (Thousand), 2016 – 2021
Figure-18: United States – Forecast for HPV DNA Test Population (Thousand), 2022 – 2027
Figure-19: United States – United States Cervical Cancer Mortality (Number), 2016 – 2021
Figure-20: United States – Forecast for United States Cervical Cancer Mortality (Number), 2022 – 2027
Figure-21: United States – Pap Smear Test Market (Million US$), 2016 – 2021
Figure-22: United States – Forecast for Pap Smear Test Market (Million US$), 2022 – 2027
Figure-23: United States – HPV DNA Test Market (Million US$), 2016 – 2021
Figure-24: United States – Forecast for HPV DNA Test Market (Million US$), 2022 – 2027
Figure-25: Canada – Cervical Cancer Test Population (Thousand), 2016 – 2021
Figure-26: Canada – Forecast for Cervical Cancer Test Population (Thousand), 2022 – 2027
Figure-27: Canada – Pap Smear Test Population (Thousand), 2016 – 2021
Figure-28: Canada – Forecast for Pap Smear Test Population (Thousand), 2022 – 2027
Figure-29: Canada – HPV DNA Test Population (Thousand), 2016 – 2021
Figure-30: Canada – Forecast for HPV DNA Test Population (Thousand), 2022 – 2027
Figure-31: Canada – Canada Cervical Cancer Mortality (Number), 2016 – 2021
Figure-32: Canada – Forecast for Canada Cervical Cancer Mortality (Number), 2022 – 2027
Figure-33: Canada – Pap Smear Test Market (Million US$), 2016 – 2021
Figure-34: Canada – Forecast for Pap Smear Test Market (Million US$), 2022 – 2027
Figure-35: Canada – HPV DNA Test Market (Million US$), 2016 – 2021
Figure-36: Canada – Forecast for HPV DNA Test Market (Million US$), 2022 – 2027
List Of Tables:
Table-01: North America – Pap Smear Test Market Share by Countries (Percent), 2016 – 2021
Table-02: North America – Forecast for Pap Smear Test Market Share by Countries (Percent), 2022 – 2027
Table-03: North America – HPV DNA Test Market Share by Countries (Percent), 2016 – 2021
Table-04: North America – Forecast for HPV DNA Test Market Share by Countries (Percent), 2022 – 2027

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information